This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bedigian, M. P Search for Related Content PubMed PubMed Citation Articles by Bedigian, M. P Social Bookmarking                         What's this?

Improving the prognosis of diabetic patients: evaluating the role of intensive versus moderate blood pressure control with selective angiotensin II receptor blocker (ARB) therapy

Novartis Pharmaceuticals, East Hanover, NJ, USA, martin. bedigian@pharma

The ABCD (Appropriate Blood Pressure Control in Diabetes) and ABCD-2V (Part 2 with Valsartan) are prospective, randomised clinical trials which will provide important data on the impact of intensive vs. moderate blood pressure (BP) control on microvascular and macrovascular complications in normotensive and hypertensive patients with type 2 diabetes mellitus (DM). The ABCD trial was a five-year study that compared the effects of intensive vs. moderate BP control on the endpoints of nephropathy, retinopathy, neuropathy, and cardiovascular disease events using a calcium channel blocker (CCB) and an angiotensin-converting enzyme (ACE) inhibitor as the primary antihypertensive agents. The recently published results of the hypertensive cohort of ABCD are reviewed herein. The follow-up study, ABCD-2V, is ongoing and was designed to compare intensive vs. moderate BP control on the same endpoints as the ABCD study, using the highly selective angiotensin II receptor blocker (ARB) valsartan as the primary antihypertensive agent. First results of ABCD-2V are expected in 2004. The baseline characteristics for the patients enrolled thus far in the hypertensive cohort of ABCD-2V are reviewed. These studies will provide insight into the role of intensive vs. moderate BP control in the management of normotensive and hypertensive patients with type 2 DM.

Key Words: type 2 diabetes • hypertension • nephropathy • retinopathy • neuropathy • ABCD-2V • valsartan • Angiotensin II receptor blocker

References

• Dupree EA, Meyer MB Role of risk factors in complications of diabetes mellitus. Am JEpidemiol 1980; 12: 100-12.
• Nelson RG, Newman JM, Knowler WC et al. Incidence of end stage renal disease in NIDDM in Pima Indians. Diabetalogia 1988; 31:730-46.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kannel WB, McGee DL Diabetes and glucose tolerance as risk factors for cardiovascular disease. Diabetes Care 1979; 2: 120-6.[Abstract]
• Knowler WC, Bennett PH, Ballantine EJ Increased incidence of retinopathy in diabetes with elevated blood pressure. N Engl J Med 1980; 301:645-50.
• Maser R. Epidemiological correlates of diabetic nephropathy. Diabetes 1989; 38:1456-61.[Abstract]
• The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Int Med 1997; 57: 2413-46.
• Savage S., Johnson Nagel N., Estacio RO et al. The ABCD (Appropriate Blood Pressure Control in Diabetes) trial: rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes. Online J Curr Clin Trials: Doc No 104,1993.
• Schrier RW, Estacio RO, Jeffers B. Appropriate Blood Pressure Control in NIDDM (ABCD) trial. Diabetologia 1996; 39(12): 1646-54.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Estacio RO, Savage S., Schrier RW et al. Baseline characteristics of participants in the appropriate blood pressure control in diabetes trial. Con Clin Trials 1996; 17: 242-57.[CrossRef]
• Estacio RO, Jeffers BW, Hiatt WR et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with diabetes and hypertension. N Eng J Med 1998; 338:645-52.[Abstract/Free Full Text]
• Estacio RO, Jeffers BW, Schrier RW et al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes: Diabetes Care 2000; 23(Suppl 2): B54-B64.[Web of Science][Medline] [Order article via Infotrieve]
• Schrier RW, Estacio RO, Bedigian MP et al. Appropriate Blood Pressure Control in Diabetes - Part 2 with Valsartan (ABCD-2V trial). Am JHypertens 1999;12(4 pt 2): 141A.
• Bedigian MP, Estacio RO, Schrier RW et al. Baseline characteristics of the hypertensive cohort of the appropriate blood pressure control in diabetes trial - part 2 with valsartan (ABCD-2V). Am J Hypertens 2000; 13(4 part 2):56-57A.
• Thogersen AM, Jansson J., Boman K. et al. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women. Circulation 1998; 98: 2241-7.[Abstract/Free Full Text]
• Despres JP, Lamarche B., Mauriege P. et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334(15):952-7.[Abstract/Free Full Text]
• Bedigian MP, Estacio RO, Schrier RW et al. Insulin, tPA and PAI-1 levels and their correlations with cardiac risk and disease factors in the hypertensive cohort of the appropriate blood pressure control in diabetes trial-part 2 with valsartan (ABCD-2V). Am J Hypertens 2000; 13(4 part 2): 100-1A.

Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 2 suppl, S25-S28 (2000)
DOI: 10.3317/jraas.2000.050


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bedigian, M. P Search for Related Content PubMed PubMed Citation Articles by Bedigian, M. P Social Bookmarking                         What's this?